News, views and contacts from the global Pharmaceutical industry

Today on Pharmaceutical Technology

Latest Features

June's top stories: 75 US staff possibly exposed to anthrax, Merck's $3.8bn Idenix deal
11 July, 2014 The Centers for Disease Control and Prevention reported that 75 Atlanta-based staff may have been unintentionally exposed to live Bacillus anthracis, and Merck reached a definitive agreement...